Investors are Digesting These Healthcare Stock Earnings Insights

Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased to $-0.65 in the quarter versus EPS of $-0.23 in the year-earlier quarter. Revenue Rose 35.12% to $19.43 million from the year-earlier quarter.

Optimer Pharmaceuticals, Inc. reported adjusted EPS loss of $0.65 per share. By that measure, the company missed the mean analyst estimate of $-0.42. It missed the average revenue estimate of $21.09 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

OPTR

Omeros Corporation (NASDAQ:OMER) had a loss and met Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share were the same at $-0.40 in the quarter as EPS of $-0.40 in the year-earlier quarter. Revenue Decreased 26.67% to $1.1 million from the year-earlier quarter.

Omeros Corporation reported adjusted EPS loss of $0.40 per share. By that measure, the company met the mean analyst estimate of $-0.40. It missed the average revenue estimate of $1.39 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

OMER

Medivation, Inc. (NASDAQ:MDVN) had a loss and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share decreased to $-0.36 in the quarter versus EPS of $0.01 in the year-earlier quarter. Revenue Rose 25.31% to $46.15 million from the year-earlier quarter.

Medivation, Inc. reported adjusted EPS loss of $0.36 per share. By that measure, the company beat the mean analyst estimate of $-0.41. It beat the average revenue estimate of $38.54 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

MDVN

PDL BioPharma, Inc. (NASDAQ:PDLI) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased 24.14% to $0.36 in the quarter versus EPS of $0.29 in the year-earlier quarter. Revenue Rose 18.7% to $91.8 million from the year-earlier quarter.

PDL BioPharma, Inc. reported adjusted EPS income of $0.36 per share. By that measure, the company beat the mean analyst estimate of $0.35. It beat the average revenue estimate of $91.69 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

PDLI

Salix Pharmaceuticals Ltd. (NASDAQ:SLXP) delivered a profit and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased 5.97% to $0.63 in the quarter versus EPS of $0.67 in the year-earlier quarter. Revenue Rose 18.39% to $202.6 million from the year-earlier quarter.

Salix Pharmaceuticals Ltd. reported adjusted EPS income of $0.63 per share. By that measure, the company missed the mean analyst estimate of $0.68. It missed the average revenue estimate of $205.94 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

SLXP

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.